gusperimus 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
immunosuppressants 1347 98629-43-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • deoxyspergualin
  • gusperimus hydrochloride
  • gusperimus trihydrochloride
  • gusperimus
  • (+/-)-Deoxyspergualin
  • gusperimus HCl
synthesized by chemical modification of spergualin; in combination with cyclosporin A prevents diabetes in predisposed NOD mice; structure given in first source; RN given refers to (-)-isomer trihydrochloride
  • Molecular weight: 387.53
  • Formula: C17H37N7O3
  • CLOGP: -0.09
  • LIPINSKI: 1
  • HAC: 10
  • HDO: 8
  • TPSA: 178.38
  • ALOGS: -3.48
  • ROTB: 17

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

Pharmaceutical products:

None

gusperimus